Michael Offin

7.8k citations
99 papers · 2.2k · 2 hit papers · h-index 24

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Occupational and environmental lung diseases
  • Oncology top 2%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research

Papers in

    • Lung Cancer Treatments and Mutations 40
    • Occupational and environmental lung diseases 20
    • Lung Cancer Diagnosis and Treatment 7
    • Lung Cancer Research Studies 11
    • Colorectal Cancer Treatments and Studies 8
    • Cancer Immunotherapy and Biomarkers 8

Michael Offin

89 papers receiving 2.2k citations

Michael Offin's Hit Papers

High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden 2019 · 309 citations
3090+2+4Years since publication100200300

Peers

Michael Offin
Comparison fields: 5 of 82
  • Pulmonary and Respiratory Medicine 1.2k
  • Oncology 893
  • Cancer Research 379
  • Hepatology 78
  • Pathology and Forensic Medicine 166
Replace James Suh with:
James Suh United States
Marine Gross‐Goupil France
Davey B. Daniel United States
Lorenza Landi Italy
Anas Gazzah France
Éric Dansin France
Carol Peña France
Vincent Haddad United Kingdom
Gene Grant Finley United States
C. Lewanski United Kingdom
Michael Offin relative to James Suh United States James Suh's profile →
Citations per field
00.5×
James Suh · 1×
Citations per year

Countries citing papers authored by Michael Offin

Since Specialization
Citations

This map shows the geographic impact of Michael Offin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Offin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Offin more than expected).

Fields of papers citing papers by Michael Offin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Offin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Offin. The network helps show where Michael Offin may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Offin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Offin Line = papers co-authored together Michael Offin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.

#Work
1
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden
Hit paper breakdown →
2019309
2
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes
Hit paper breakdown →
2019273
3 2018239
4 201885
5 201884
6 201875
7 201967
8 201166
9 201950
10 202049
11 201844
12 202043
13 201943
14 201837
15 202136
16 201934
17 202131
18 202031
19 201829
20 201127

About Michael Offin

Michael Offin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Surgery, having authored 99 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (40 papers), Occupational and environmental lung diseases (20 papers), Cancer Genomics and Diagnostics (19 papers), Lung Cancer Research Studies (11 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (893 citations), Cancer Research (379 citations), Hepatology (78 citations) and Pathology and Forensic Medicine (166 citations). Michael Offin has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Charles M. Rudin, Mark G. Kris, Alexander Drilon, Marc Ladanyi, Maria E. Arcila, Bob T. Li, Matthew D. Hellmann, Gregory J. Riely, Helena A. Yu and Hira Rizvi. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, JCO Precision Oncology, Clinical Cancer Research and Radiotherapy and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact